ID   AC6C3
AC   CVCL_B0J5
SY   AC6C3(IH8)
DR   ATCC; HB-10305
DR   Wikidata; Q108819823
RX   Patent=US5434076;
RX   PubMed=2032733;
RX   PubMed=7493338;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10305.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 32 kDa protein on the surface of many cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JJ88 ! SPAZ-4
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=US5434076;
RA   Freedman R.S., Ioannides C.G., Tomasovic B.J., Patenia R.S.;
RT   "Tumor-specific, cell surface-binding monoclonal antibodies.";
RL   Patent number US5434076, 18-Jul-1995.
//
RX   PubMed=2032733; DOI=10.1089/hyb.1991.10.21;
RA   Freedman R.S., Ioannides C.G., Tomasovic B.J., Patenia R.S.,
RA   Zhang H.-Z., Liang J.C., Edwards C.L.;
RT   "Development of a cell surface reacting human monoclonal antibody
RT   recognizing ovarian and certain other malignancies.";
RL   Hybridoma 10:21-33(1991).
//
RX   PubMed=7493338;
RA   Quadri S.M., Malik A.B., Tang X.-Z., Patenia R.S., Freedman R.S.,
RA   Vriesendorp H.M.;
RT   "Preclinical analysis of intraperitoneal administration of
RT   111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.";
RL   Cancer Res. 55:5736s-5742s(1995).
//